Pharmlog Pharma Logistik Sustainability Profile
Pharmlog Pharma Logistik, commonly referred to as Pharmlog, is a leading logistics provider in the pharmaceutical industry, headquartered in Germany. Established in 2003, the company has rapidly expanded its operations across Europe, specialising in temperature-controlled logistics and supply chain solutions tailored for the healthcare sector. Pharmlog offers a range of core services, including warehousing, distribution, and regulatory compliance, ensuring the safe and efficient delivery of pharmaceutical products. Their commitment to quality and innovation has positioned them as a trusted partner for numerous pharmaceutical companies. With a focus on maintaining the integrity of sensitive products, Pharmlog has achieved significant milestones, reinforcing its reputation as a key player in the pharmaceutical logistics market.
DitchCarbon Score
How does Pharmlog Pharma Logistik's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmlog Pharma Logistik's score of 45 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmlog Pharma Logistik's reported carbon emissions
In 2023, PharmLog Pharma Logistik reported total carbon emissions of approximately 4,698,000 kg CO2e. This figure includes 389,200 kg CO2e from Scope 1 emissions, 1,017 kg CO2e from Scope 2 emissions, and a significant 4,308,600 kg CO2e from Scope 3 emissions. The Scope 3 emissions breakdown reveals that downstream transportation and distribution accounted for about 3,216,800 kg CO2e, while purchased goods and services contributed approximately 650,000 kg CO2e. PharmLog has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 46% by 2030, using 2019 as the base year. This target has been approved by the Science Based Targets initiative (SBTi) and is aligned with the goal of limiting global warming to 1.5°C. The company also plans to measure and reduce its Scope 3 emissions, reflecting a comprehensive approach to tackling its carbon footprint. The emissions data for previous years shows a trend of decreasing total emissions, from approximately 6,692,000 kg CO2e in 2022 and 6,525,000 kg CO2e in 2021, indicating progress towards their reduction targets. The commitment to sustainability is further underscored by the company's status as a current subsidiary of Viatris Inc., which may influence its climate strategies and reporting practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 365,800 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 1,290,000 | 0,000 | 0,000 | 0,000 |
| Scope 3 | 6,180,900 | 0,000,000 | 0,000,000 | 0,000,000 |
How Carbon Intensive is Pharmlog Pharma Logistik's Industry?
How Carbon Intensive is Pharmlog Pharma Logistik's Location?
Pharmlog Pharma Logistik's Scope 3 Categories Breakdown
Pharmlog Pharma Logistik's Scope 3 emissions, which decreased by 32% last year and decreased by approximately 30% since 2020, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 75% of Scope 3 emissions.
Top Scope 3 Categories
Pharmlog Pharma Logistik's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pharmlog Pharma Logistik has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Tnt Express
Frequently Asked Questions
Common questions about Pharmlog Pharma Logistik's sustainability data and climate commitments